Management of sexual dysfunction in Parkinson's disease

Therapeutic Advances in Neurological Disorders

Volumn 4, Issue 6, 2011, Pages 375-383

  Bronner, Gila ^a   Vodusek, David B ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

desire; erectile dysfunction; hypersexuality; management; orgasm; Parkinson's disease; sexual counseling; sexual dysfunction

Indexed keywords

APOMORPHINE; CLOMIPRAMINE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; LUBRICATING AGENT; NITRIC OXIDE; PAPAVERINE; PAROXETINE; PHENTOLAMINE; PROSTAGLANDIN E1; SERTRALINE; SILDENAFIL; TADALAFIL; TESTOSTERONE; VARDENAFIL; VASODILATOR AGENT;

ANDROGEN DEFICIENCY; BLADDER EMPTYING; BRADYKINESIA; BRAIN DEPTH STIMULATION; CONSERVATIVE TREATMENT; DEPRESSION; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; DYSKINESIA; DYSPEPSIA; EJACULATION; ERECTILE DYSFUNCTION; FLUSHING; HEADACHE; HEALTH CARE PERSONNEL; HUMAN; HYPERSALIVATION; HYPERSEXUALITY; LIBIDO; LUBRICATION; MOTOR CONTROL; MUSCLE RIGIDITY; NAUSEA; NEUROGENIC BLADDER; ORGASM; OVERACTIVE BLADDER; PARKINSON DISEASE; PETECHIA; PHYSICIAN; PRIAPISM; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SEXUAL AROUSAL; SEXUAL BEHAVIOR; SEXUAL COUNSELING; SEXUAL DYSFUNCTION; SEXUAL EDUCATION; SEXUAL FUNCTION; SEXUALITY; SIDE EFFECT; SKIN BRUISING; SKIN EDEMA; SUBTHALAMIC NUCLEUS; SWEATING; TREMOR; URGE INCONTINENCE; URINE INCONTINENCE; VISUAL DISORDER;

EID: 82955213570     PISSN: 17562856     EISSN: 17562864     Source Type: Journal    
DOI: 10.1177/1756285611411504     Document Type: Article

References (67)

1. Addis I.B. van Den Eeden S.K. Wassel-Fyr C.L. Vittinghoff E. Brown J.S. Thom D.H. et al. (2006) Sexual activity and function in middle-aged and older women. Obstet Gynecol 107: 755–764.
2. Basson R. (1996) Sexuality and Parkinson's disease. Parkinsonism Relat Disord 2: 177–185.
3. Basson R. Rees P. Wang R. Montejo A.L. Incrocci L. (2010) Sexual function in chronic illness. J Sex Med 7: 374–388.
4. Bostwick J.M. Hecksel K.A. Stevens S.R. Bower J.H. Ahlskog J.E. (2009) Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease. Mayo Clin Proc 84 (4): 310–316.
5. Broen M. Duits A. Visser-Vandewall V. Temel Y. Winogrodzka A. (2011) Impulse control and related disorders in Parkinson's disease patients treated with bilateral subthalamic nucleus stimulation: a review. Parkinsonism Relat Disord, in press.
6. Bronner G. (2009) Practical strategies for the management of sexual problems in Parkinson's disease. Parkinsonism Relat Dis 15(Suppl. 3): s96–s100.
7. Bronner G. Elran E. Golomb J. Korczyn A.D. (2010) Female sexuality in multiple sclerosis–the multidimensional nature of the problem and the intervention. Acta Neurol Scand 21: 289–301.
8. Bronner G. Royter V. Korczyn A.D. Giladi N. (2004) Sexual dysfunction in Parkinson's disease. J Sex Marital Ther 30: 95–105.
9. Brown R.G. Jahanshahi N. Quinn N. Marsden C.D. (1990) Sexual function in patients with Parkinson's disease and their partners. J Neurol Neurosurg Psychiatry 53: 480–486.
10. Cannas A. Solla P. Floris G.L. Serra G. Tacconi P. Marrosu M.G. (2007) Aberrant sexual behaviours in Parkinson's disease during dopaminergic treatment. J Neurol 254: 110–112.
11. Castelli L. Perozzo P. Genesia M.L. Torre E. Pesare M. Cinquepalmi A. et al. (2004) Sexual well being in parkinsonian patients after deep brain stimulation of the subthalamic nucleus. J Neurol Neurosurg Psychiatry 75: 1260–1264.
12. Celikel E. Ozel-Kizil E.T. Akbostanci M.C. Cevik A. (2008) Assessment of sexual dysfunction in patients with Parkinson's disease: a case–control study. Eur J Neurol 15: 1168–1172.
13. Chaudhuri K.R. Healy D.G. Schapira A.H. (2006) Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 5: 235–245.
14. Christenson G.A. Faber R.J. de Zwaan M. Raymond N.C. Specker S.M. Ekern M.D. et al. (1994) Compulsive buying: descriptive characteristics and psychiatric comorbidity. J Clin Psychiatry 55: 5–11.
15. Chung T.H. Deane K.H.O. Ghazi-Noori S. Rickards H. Clarke C.E. (2003) Systematic review of antidepressant therapies in Parkinson's disease. Parkinsonism Relat Disord 10: 59–65.
16. Clayton A. Ramamurthy S. (2008) The impact of physical disease on sexual dysfunction. Adv Psychosom Med 29: 70–88.
17. Denil J. Ohl D. Smythe C. (1996) Vacuum erection device in spinal cord injured men: patient and partner satisfaction. Arch Phys Med Rehabil 77: 750–753.
18. Dodd M.L. Klos K.J. Bower J.H. Geda Y.E. Josephs K.A. Ahlskog J.E. (2005) Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol 62: 1377–1381.
19. Driver-Dunckley E.D. Noble B.N. Hentz J.G. Evidente V.G. Caviness J.N. Parish J. et al. (2007) Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome. Clin Neuropharmacol 30: 249–255.
20. Ferreri F. Agbokou C. Gauthier S. (2006) Recognition and management of neuropsychiatric complications in Parkinson's disease. CMAJ 175: 1545–1552.
21. Fernandez H.H. Durso R. (1998) Clozapine for dopaminergic-induced paraphilias in Parkinson's disease. Mov Disord 13: 597–598.
22. Giladi N. Weitzman N. Schreiber S. Shabtai H. Peretz C. (2007) New-onset heightened interest or drive for gambling, eating, shopping or sexual activity in patients with Parkinson's disease: the role of dopamine agonist treatment and age at motor symptoms onset. J Psychopharmacol 21: 501–506.
23. Giovannoni G. O'Sullivan J.D. Turner K. Manson A.J. Lees A.J. (2000) Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 68: 423–428.
24. Hand A. Gray W.K. Chandler B.J. Walker R.W. (2010) Sexual and relationship dysfunction in people with Parkinson's disease. Parkinsonism Relat Disord 16: 172–176.
25. Heaton J.P.W. (2000) Apomorphine: an update of clinical trial results. Int J Impot Res 12(Suppl. 4): S67–S73.
26. Hussain I.F. Brady C.M. Swinn M.J. Mathias C.J. Fowler C.J. (2001) Treatment of erectile dysfunction with sildenafil citrate (Viagra) in Parkinsonism due to Parkinson's disease or multiple system atrophy with observation on orthostatic hypotension. J Neurol Neurosurg Psychiatry 71: 371–374.
27. Jacobs H. Vieregge A. Vieregge P. (2000) Sexuality in young patients with Parkinson's disease: a population based comparison with healthy controls. J Neurol Neurosurg Psychiatry 69: 550–552.
28. Jiménez-Jiménez F.J. Sayed Y. García-Soldevilla M.A. Barcenilla B. (2002) Possible zoophilia associated with dopaminergic therapy in Parkinson disease. Ann Pharmacother 36: 1178–1179.
29. Klos K.J. Bower J.H. Josephs K.A. Matsumoto J.Y. Ahlskog J.E. (2005) Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy. Parkinsonism Relat Disord 11: 381–386.
30. Koller W.C. Vetere-Overfield B. Williamson A. Busenbark K. Nash J. Parrish D. (1990) Sexual dysfunction in Parkinson's disease. Clin Neuropharmacol 13: 461–463.
31. Korczyn A.D. (1990) Autonomic nervous system disturbances in Parkinson's disease. Adv Neurol 53: 463–468.
32. Korpelainen J.T. Hiltunen P. Myllylä V.V. (1998) Moclobemide-induced hypersexuality in patients with stroke and Parkinson's disease. Clin Neuropharmacol 21: 251–254.
33. Kummer A. Cardoso F. Teixeira A.L. (2009) Loss of libido in Parkinson's disease. J Sex Med 6: 1024–1031.
34. Laumann E.O. Glasser D.B. Neves R.C.S. Moreira E.D. (2009) A Population-based survey of sexual activity, sexual problems and associated help-seeking behavior patterns in mature adults in the United States of America. Int J Impot Res 21 (3): 171–8.
35. Lipe H. Longstreth W.T. Jr Bird T.D. Linde M. (1990) Sexual function in married men with Parkinson's disease compared to married men with arthritis. Neurology 40: 1347–1349.
36. Merims D. Giladi N. (2008) Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease. Parkinsonism Relat Disord 14: 273–280.
37. Moore O. Gurevich T. Korczyn A.D. Anca M. Shabtai H. Giladi N. (2002) Quality of sexual life in Parkinson's disease. Parkinsonism Relat Disord 8: 243–246.
38. Nurnberg H.G. Hensley P.L. Heiman J.R. Croft H.A. Debattista C. Paine S. (2008) Sildenafil treatment of women with antidepressant-associated sexual dysfunction: a randomized controlled trial. JAMA 300: 395–404.
39. Nurnberg H.G. Siegel R. (2006) Effects of sildenafil citrate treatment on ejaculatory / orgasm delay and erectile dysfunction in serotonergic antidepressant-associated sexual dysfunction. J Urol 175: 300.
40. Okun M.S. McDonald W.M. de Long M.R. (2002 a) Refractory nonmotor symptoms in male patients with Parkinson disease due to testosterone deficiency. Arch Neurol 59: 807–811.
41. Okun M.S. Walter B.L. McDonald W.M. Tenover J.L. Green J. Juncos J.L. et al. (2002 b) Beneficial effects of testosterone replacement for the nonmotor symptoms of Parkinson disease. Arch Neurol 59: 1750–1753.
42. O'Sullivan J. Hughes A. (1998) Apomorphine-induced penile erections in Parkinson's disease. Mov Disord 13: 536–539.
43. Porst H. (1996) The rationale for prostaglandin E 1 in erectile failure: a survey of worldwide experience. J Urol 155: 802–815.
44. Raffaele R. Vecchio I. Giammusso B. Morgia G. Brunetto M.B. Rampello L. (2002) Efficacy and safety of fixed-dose oral sildenafil in the treatment of sexual dysfunction in depressed patients with idiopathic Parkinson's disease. Eur Urol 41: 382–386.
45. Ready R.E. Friedman J. Grace J. Fernandez H. (2004) Testosterone deficiency and apathy in Parkinson's disease: a pilot study. J Neurol Neurosurg Psychiatry 75: 1323–1326.
46. Rees P.M. Fowler C.J. Maas C.P. (2007) Sexual function in men and women with neurological disorders. Lancet 369: 512–525.
47. Salonia A. Rigatti P. Montorsi F. (2003) Sildenafil in erectile dysfunction: a critical review. Curr Med Res Opin 19: 241–262.
48. Sakakibara R. Shinotoh H. Uchiyama T. Sakuma M. Kashiwado M. Yoshiyama M. et al. (2001) Questionnaire-based assessment of pelvic organ dysfunction in Parkinson's disease. Auton Neurosci 92: 76–85.
49. Savica R. Rocca W.A. Ahlskog J.E. (2010) When does Parkinson disease start?. Arch Neurol 67: 798–801.
50. Seidman S.N. Pesce V. Roose S.P. (2003) High dose sildenafil citrate for selective serotonin reuptake inhibitor-associated ejaculatory delay: open clinical trial. J Clin Psychiatry 64: 721–725.
51. Shulman L.M. Taback R.L. Rabenstein A.A. Weiner W.J. (2002) Non-recognition of depression and other non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord 8: 193–197.
52. Singer C. Weiner W.J. Sanchez-Ramos I.R. Ackerman M. (1991) Sexual function in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 54: 942.
53. Truong D.D. Bhidayasiri R. Wolters E. (2008) Management of non-motor symptoms in advanced Parkinson disease. J Neurol Sci 266: 216–228.
54. Uitti R.J. Tanner C.M. Rajut A.H. Goetz C.G. Klawan H.L. Thiessen B. (1989) Hypersexuality in antiparkinsonian therapy. Clin Neuropharmacol 12: 375–383.
55. Verschuren J.E. Enzlin P. Dijkstra P.U. Geertzen J.H. Dekker R. (2010) Chronic disease and sexuality: a generic conceptual framework. J Sex Res 47: 153–170.
56. Vitale C. Santangelo G. Trojano L. Verde F. Rocco M. Grossi D. et al. (2011) Comparative neuropsychological profile of pathological gambling, hypersexuality, and compulsive eating in Parkinson's disease. Mov Dis, in press.
57. Voon V. Hassan K. Zurowski M. de Souza M. Thomsen T. Fox S. et al. (2006) Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology 67: 1254–1257.
58. Voon V. Sohr M. Lang A.E. Potenza M.N. Siderowf A.D. Whetteckey J. et al. (2011) Impulse control disorders in Parkinson disease: A multicenter case-control study. Ann Neurol.
59. Weintraub D. Koester J. Potenza M.N. Siderowf A.D. Stacy M. Voon V. et al. (2010) Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 67: 589–595.
60. Weintraub D. Siderowf A.D. Potenza M.N. Goveas J. Morales K.H. Duda J.E. et al. (2006) Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol 63: 969–973.
61. Welch M. Hung L. Waters C.H. (1997) Sexuality in women with Parkinson's disease. Mov Disord 12: 923–927.
62. Wermuth L. Stenager E. (1995) Sexual problems in young patients with Parkinson's disease. Acta Neurol Scand 91: 453–455.
63. Wielinski C.L. Varpness S.C. Erickson-Davis C. Paraschos A.J. Parashos S.A. (2010) Sexual and relationship satisfaction among persons with young- Parkinson's disease. J Sex Med 7: 1438–1444.
64. World Association for Sexual Health. (2008) Sexual health for the millennium. World Association for Sexual Health: Minneapolis MN.
65. Zesiewicz T.A. Helal M. Hauser M.D. (2000) Sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men with Parkinson's disease. Mov Disord 15: 305–308.
66. Zesiewicz T.A. Sullivan K.L. Arnulf I. Chaudhuri K.R. Morgan J.C. Gronseth G.S. et al. (2010) Practice Parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 74 (11): 924–931.
67. Zusman R.M. Morales A. Glasser D.B. Osterloh I.H. (1999) Overall cardiovascular profile of sildenafil citrate. Am J Cardiol 83(5A): 35C–44C.